1. schachererjm
2. kungfuninjaninja
3. juliomuneca476
4. cwhitebiz
5. 296brenda44
1.kungfuninjaninja 05/06/2018
2.juliomuneca476 05/18/2018
Positive drug update for ADVM-022 macular degeneration treatment
3.cwhitebiz 08/27/2018
Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema
4.kungfuninjaninja 05/01/2018
Adverum Biotechnologies Announces Long-term Preclinical Efficacy Data on ADVM-022 Gene Therapy in Wet AMD
5.schachererjm 02/15/2018
I have never even heard of these guys
6.kungfuninjaninja 08/09/2018
Reports Q2 EPS loss of $0.30 and revenue of $0.49M (+6.5% Y/Y)
7.schachererjm 02/12/2018
Adverum Biotechnologies Announces Closing of $69 Million Public Offering
8.schachererjm 02/07/2018
Commenced an underwritten public offering of its common stock
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW